DNA N6-Methyladenine Modification in Eukaryotic Genome
- Front Genet. 2022 Jun 24:13:914404. doi: 10.3389/fgene.2022.914404.
- 1. School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
- 2. First School of Clinical Medicine, Anhui Medical University, Hefei, China.
- 3. First Affiliated Hospital of Anhui Medical University, Hefei, China.
- 4. Second School of Clinical Medicine, Anhui Medical University, Hefei, China.
DNA methylation is treated as an important epigenetic MARK in various biological activities. In the past, a large number of articles focused on 5 mC while lacking attention to N6-methyladenine (6 mA). The presence of 6 mA modification was previously discovered only in prokaryotes. Recently, with the development of detection technologies, 6 mA has been found in several eukaryotes, including protozoans, metazoans, Plants, and fungi. The importance of 6 mA in prokaryotes and single-celled eukaryotes has been widely accepted. However, due to the incredibly low density of 6 mA and restrictions on detection technologies, the prevalence of 6 mA and its role in biological processes in eukaryotic organisms are highly debated. In this review, we first summarize the advantages and disadvantages of 6 mA detection methods. Then, we conclude existing reports on the prevalence of 6 mA in eukaryotic organisms. Next, we highlight possible methyltransferases, demethylases, and the recognition proteins of 6 mA. In addition, we summarize the functions of 6 mA in eukaryotes. Last but not least, we summarize our point of view and put forward the problems that need further research.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Cancer
-
target: Endogenous Metabolite; Nucleoside Antimetabolite/Analog; DNA/RNA Synthesis; Reference StandardsResearch Areas: Cancer